title: Controversies in Screening and Diagnosis of Gestational Diabetes: Cuba's Position.
abstract: Gestational diabetes is the most common endocrine disorder affecting pregnant women and its prevalence is on the rise. Prevalence in Cuba is about 5.8%, and global prevalence ranges from 2% to 18% depending on the criteria applied. Gestational diabetes can lead to adverse gestational outcomes, such as fetal death, preterm delivery, dystocia, perinatal asphyxia and neonatal complications. Prompt, accurate diagnosis allowing early treatment can benefit both mother and child. The disease is asymptomatic, so clinical laboratory testing plays a key role in its screening and diagnosis. Cuba's approach to diabetes screening and diagnosis differs from some international practices. All pregnant women in Cuba are screened with a fasting plasma glucose test and diagnosed using modified WHO criteria. Some international recommendations are to skip the screening step and instead follow the diagnostic criteria of the Hyperglycemia and Adverse Pregnancy Outcomes study. In Cuba, gestational outcomes for women with diabetes (including gestational diabetes) are satisfactory (preeclampsia 5%; preterm delivery 12%; neonatal macrosomia 7.5%; congenital abnormalities 4.3% and perinatal deaths 4.8%). These data do not indicate a need to change established screening and diagnostic criteria. KEYWORDS Gestational diabetes, screening, diagnosis, early detection, early diagnosis, Cuba.
authors: National Endocrinology Institute (INEN), Havana, Cuba. celsocruz@infomed.sld.cu.
authors: Jeddú
authors: J
authors: Cruz-Hernández
authors: Pilar
authors: P
authors: Hernández-García
authors: Jacinto
authors: J
authors: Lang-Prieto
authors: Marelys
authors: M
authors: Yanes-Quesada
authors: Ileydis
authors: I
authors: Iglesias-Marichal
authors: Antonio
authors: A
authors: Márquez-Guillén
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D003462:Cuba / Q000453:epidemiology; D016640:Diabetes, Gestational / Q000175:diagnosis* / Q000453:epidemiology; D042241:Early Diagnosis; D005260:Female; D005951:Glucose Tolerance Test; D006291:Health Policy; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D011247:Pregnancy; D011256:Pregnancy Outcome; D015995:Prevalence
chemical_list: D001786:Blood Glucose